Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

China · Delayed Price · Currency is CNY

19.30

+0.17 (0.89%)

Jun 18, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013
Pharmaceuticals	344.45M	470.79M	497.29M	507.38M	438.99M
Pharmaceuticals Growth	-26.84%	-5.33%	-1.99%	15.58%	16.93%
Total	344.45M	470.79M	497.29M	507.38M	438.99M
Total Growth	-26.84%	-5.33%	-1.99%	15.58%	16.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013
South China	84.87M	-	-	-	-
East China	97.83M	-	-	-	-
North China	47.46M	-	-	-	-
Northwest China	24.80M	-	-	-	-
Central China	35.85M	-	-	-	-
Southwest China	39.40M	-	-	-	-
Northeast China	5.65M	-	-	-	-
Overseas	1.41M	-	-	-	-
Total	337.27M	-	-	-	-